City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs
The Cambridge, Massachusetts company is offering 9.72 million shares at $17 to $19 each and plans to list on Nasdaq under the symbol CTY
The Cambridge, Massachusetts company is offering 9.72 million shares at $17 to $19 each and plans to list on Nasdaq under the symbol CTY